ATTORNEY NEWSLETTER
Healthcare Fraud on the Government
Whistleblowers Lead the Way in Recoveries
Outlook for 2019
In 2018, the volume of False Claims Act (FCA) litigation remained high, and health care-related qui tam (i.e., whistleblower) cases continued to lead the way. Data from 2018 suggests that pharmaceutical companies, hospitals, and home health care companies are the leading defendants in FCA health care cases. Insiders such as current and former employees remain the most common source of whistleblower cases. The California and San Francisco whistleblower attorneys at Evans Law Firm, Inc. represent whistleblowers with information regarding FCA violations by pharmaceutical companies, skilled nursing facilities, medical device manufacturers, labs, clinics, hospitals, and physician groups. If you have credible information for a healthcare fraud whistleblower case or any other whistleblower case in California, call us today at (415)441-8669 and we can help.
Despite whistleblower success in obtaining recovery, government intervention rates in these cases remain low. This trend is expected to continue in light of the Trump Administration’s corporatist disdain of such suits. As one observer put it[1], the current administration’s position is “inexplicable” given whistleblower prosecution of cases where the government has been ripped off. Speaking about Big Pharma cases in particular, he went on to say, “These lawsuits shine a light on underhanded tactics being used to infiltrate medical offices with Big Pharma-funded nurses and billing staff acting as undercover sales agents for these companies.” [“These cases are] about protecting taxpayers from fraud and abuse …and it’s inexplicable that our co-plaintiffs – the Department of Justice – would seek to drop these questions at this time. This fight is not over, and we hope Congress is watching.”
We at Evans Law Firm agree. See our recent blog “Standing Up for Rights” at https://www.evanslaw.com/san-francisco-and-california-consumer-attorneys-standing-up-for-rights/. Our whistleblower/qui tam lawyers are dedicated to pursuing False Claims Act cases regardless of the current administration’s capitulation to big corporations. Public health and safety are the center of much FCA healthcare litigation whether the fraud is unapproved medication, unnecessary services, false diagnoses or profits over proper care. Recouping money paid out fraudulently is important; ensuring the health and safety of Americans even more so.
Contact Us
In addition to healthcare fraud whistleblower cases, our attorneys also handle whistleblower cases before the Internal Revenue Service (IRS) for offshore tax avoidance schemes, and securities fraud whistleblower cases before the Securities and Exchange Commission (SEC) and Commodity Futures Trading Commission (CFTC). If you or a loved one has information regarding false claims in San Francisco or elsewhere in California, offshore tax avoidance schemes against the IRS, or securities fraud in violation of SEC and CFTC regulations, contact Ingrid M. Evans and the other Evans Law Firm whistleblower and false claims attorneys at (415) 441-8669, or by email at <a href=”mailto:info@evanslaw.com”>info@evanslaw.com</a>. Our attorneys have experience with complex financial contracts and large insurance companies. We can help guide your case through a jury trial or toward an equitable settlement. We handle cases involving financial elder abuse, whole life insurance and universal life insurance, and indexed, variable, and fixed annuities.
[1] Mark Lanier, a lawyer in Houston. See more of his comments and a Forbes January 10, 2019 article on FCA trends at https://www.forbes.com/sites/legalnewsline/2019/01/10/trumps-doj-acts-on-threat-to-trial-lawyers-who-file-lawsuits-on-behalf-of-the-government/#4b4b7ca2441f
